2cureX’s CEO Ole Thastrup will join Folkemødet 2018 in Denmark
May 2, 2018
2cureX managed a successful IPO at Nasdaq First North in Stockholm November 24th 2017 and is preparing to launch its proprietary technology IndiTreat® in the Nordics, the United Kingdom and Germany. CEO Ole Thastrup says; “We feel honored to be seen as one of the new innovative Bio-Tech companies and to share our experience and best practices in building 2cureX, in order to help define prerequisites that will increase innovation and business opportunities within the Life Science sector”
The Danish Folkemødet is organized by Foreningen Folkemødet and participation is free. For further information, please visit https://folkemoedet.dk/
Sedermera Fondkommission is the Certified Adviser of 2cureX.
For more information about 2cureX:
Ole Thastrup, CEO
Phone: +45 22 11 53 99